Introduction
Zymosan, a particulate material from the cell wall of yeast, is capable of activating the alternative pathway of the complement system (Pillemer, Blum, Lepow, Ross, Todd & Wardlaw, 1954) and induces secretion of lysosomal enzymes (Weissmann, Dukor & Zurier, 1971; Schorlemmer, Edwards, Davies & Allison, 1977) and release of prostaglandins, leukotriene C and leukotriene B4 (Zurier & Sayadoff, 1975; Doig & Ford-Hutchinson, 1980; Davidson, Smith & FordHutchinson, 1980; Rouzer, Scott, Cohn, Blackburn & Manning, 1980; Claesson, Lundberg & Malmsten, 1981) from polymorphonuclear leukocytes (PMN) and macrophages. Zymosan is also known to induce several types of experimental models of inflammation such as interstitial pneumonitis (Edwards, Wagner & Seal, 1976) , hypersensitivity pneumonitis (Barrios, Santos, Figueroa & Reyes, 1980) , chronic muscle inflammation (Green & Mangan, 1980) , arthritis (Keystone, Schorlemmer, Pope & Allison 1977) and rabbit skin oedema (Williams, 1979; Williams & Jose, 1981) . In those models, however, there are some practical differences in making quantitative measurements of the exudative and proliferative components of the inflammatory process, especially in quantifying leukocyte infiltration.
In the present study, an experimental model of inflammation caused by zymosan, designated the zymosan-air-pouch inflammation, was induced in an air-pouch prepared on the dorsum of rats in order to overcome the above-mentioned difficulties. To characterize this inflammation model exudate accumulation, migration of inflammatory cells into the pouch and the amount of granulation tissue formed ip the wall of the pouch were measured, together with histological observation of the pouch wall tissue. In addition, the effects of dexamethasone, a steroidal anti-inflammatory drug, and K-76COONa, a specific inhibitor of activation of the fifth component of the complement system (Hong, Kinoshita, Miyazaki, Izawa & Inoue, 1979) , on the development of this type of inflammation were examined.
Methods

Casein-air-pouch inflammation Animals
Male rats of the Sprague-Dawley strain (specific pathogen-free, 4 weeks old and weighing 60-80g) were purchased from Charles River Japan, Inc., Kanagawa, Japan, and were maintained on laboratory food (CRF-1, Charles River Japan) and chlorinated tap water in a rack provided with lamina flow of clean air for 2 weeks before use.
Materials
Zymosan A, trypsin (trypsin type III) and dexamethasone were obtained from Sigma Chemical Co., St. Louis, MO., U.S.A. Sodium carboxymethyl cellulose (CMC, Cellogen F-3H, Dai-ichi Kogyo Seiyaku Co., Ni-igata, Japan) and K-76COONa, sodium 6,7-dihydroxy-2,5,5,8a-tetramethyl-1,2,3, 4,4a,5,6,7,8,8a -decahydronaphthalene-1-spiro-2'-(7'-carboxylate-6'-formyl-4'-hydroxy-2', 3'-dihydrobenzofuran), (Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan), a specific inhibitor of the fifth component of the complement system (Hong et al., 1979) , were generous gifts. Casein (casein nach Hammarsten) was obtained from E. Merck, Darmstadt, W. Germany.
Zymosan-air-pouch inflammation
Rats were injected with 8 ml of air subcutaneously on the back , under light ether anaesthesia, to make an air-pouch in the shape of an ellipsoid or oval.
Twenty-four hours later 4 ml of 1.6% (w/v) zymosan suspension in 0.8% (w/v) solution of CMC in 0.9% w/v NaCl solution (saline), supplemented with antibiotics (0.1 mg penicillin G potassium and 0.1 mg dihydrostreptomycin sulphate per 1.0 ml), was injected into the preformed air-pouch to induce an inflammatory response which we call the 'zymosanair-pouch inflammation'. The above zymosan suspension in the CMC vehicle will be designated 'zymosan-CMC'. To prepare the zymosan-CMC, zymosan particles were washed with about a 30 fold volume of saline, sterilized by autoclaving at 110°C for 15 min and resuspended at a concentration of 26.7 mg ml -in sterile saline. Three volumes of the above sterile zymosan suspension and two volumes of 2% (w/v) CMC solution containing NaCl at a concentration of 0.9% (w/v) (autoclaved at 110°C for 15 min) were mixed; to this antibiotics were then added, as described above, to yield the zymosan-CMC. A 0.8% solution of CMC in saline, autoclaved and containing added antibiotics as described above, was used in the control experiments and is designated 'vehicle-CMC'.
The air-pouch was prepared on the back of rats as mentioned above, and 24 h later 4 ml ofa solution of 0.8% (w/v) CMC 
Measurement of the number of inflammatory cells
At suitable times after injection of the zymosan-CMC, casein-CMC or vehicle-CMC into the airpouch, rats were killed by cutting the carotid artery under light ether anaesthesia. Hair on the back was clipped off and the skin was incised at the top of the pouch with scissors to make an opening (0.5-1.0 cm in length) and then the rat was held by hand to keep the abdominal side up and the pouch fluid pressed out carefully from the opening and collected in a plastic cup. The free cells in the pouch fluid were counted in a haemocytometer. As preliminary experiments indicated that the zymosan-air-pouch inflammation was characterized by a heavy aggregation of inflammatory cells sticking to the surface of the inner pouch wall, as shown in Figure 3 (b), 0.05% (w/v) trypsin in Hanks' balanced salt solution was infused into the pouch after the collection of the pouch fluid and then the dead rat was kept at 37°C for 4 h in an incubator in order to disaggregate those cells sticking onto the pouch wall. The disaggregated cells were counted in a haemocytometer immediately after finishing the trypsinization. Although no significant aggregation of inflammatory cells on the pouch wall was observed in the histological specimens of casein-airpouch inflammation (data not shown), the same trypsinization procedure was followed in order to make the cell counts comparable between the two types of air-pouch inflammation.
Measurement of the wet weight of granulation tissue
Granulation tissue which was formed as a wall of the pouch was carefully excised from surrounding loose connective tissues and weighed.
Histological examinations
At appropriate times after the injection of the zymosan-CMC, pouch wall tissues were excised together with the dorsal skin, fixed immediately in phosphate buffered (pH 7.0) 3.7% formaldehyde solution for 48 h, embedded in paraffin, sectioned at 2pm width and stained with haematoxylin and eosin.
Drug treatment
Dexamethasone dissolved in 0.1 ml of 99.5 % ethanol was injected directly into each pouch immediately after the injection of 4 ml of the zymosan-CMC or casein-CMC into the preformed air-pouch. The injection of 0.1 ml of 99.5 % ethanol into the pouch had been shown, in preliminary experiments, not to affect the course of the inflammatory response in this model. When K-76COONa was administered, it was dissolved in distilled water by raising the pH to 7.4 with O.1N NaOH in order to neutralize the phenolic hydroxy group of the molecule, and the resultant solution of K-76COONa was then diluted to the desired concentration, made isotonic by adding NaCl and used in place of saline to prepare the zymosan suspension according to the procedure described already.
Results
Fluid exudation in the pouch When the zymosan-CMC was injected to induce inflammation in a preformed air-pouch, the volume of the pouch fluid increased slowly during the first 48 h. Thereafter accumulation of the pouch fluid intensified as indicated in Figure 1 . On the other hand, when the vehicle-CMC was injected as control, the volume of the pouch fluid decreased gradually with the passage of time (Figure 1 ), and at day 5 there was only a trace of viscous fluid. Twenty-four hours after the initiation of the zymosan-air-pouch inflammation, the volume of pouch fluid reached a level about twice as high as that in the control rats which were injected with the vehicle-CMC; the difference between the two groups increased to about three fold at48h.
Inflammatory cells in the pouch
In the pouch injected with zymosan-CMC, a large Figure 2 illustrates the marked differences between the zymosan-CMC and vehicle-CMC groups, throughout the experimental periods, in the rate of migration of the inflammatory cells into the pouch. At 4 h the total number of cells in the zymosan-CMC group was more than three times as much as that of the vehicle-CMC group. Thereafter, the differences was further augmented with the passage of time.
Granulation tissue
In the zymosan-CMC group, distinct granulation tissue was formed as a wall of the pouch and by day 5 it became quite tough enough to be easily separable from the surrounding subcutaneous tissues. The wet weight of the granulation tissue isolated was measured after removing a layer of the inflammatory cells aggregated on the inner surface of the pouch. However, in the vehicle-CMC group the granulation tissue was jelly-like and fragile. As reflected by measurement of the wet weight of the granulation tissues (Table 1) , there was a distinct difference in the proliferative process betweeen the zymosan-CMC and vehicle-CMC groups.
Histological observation
Twenty-four hours after the injection of the vehicle-CMC subcutaneous tissues surrounding the pouch were only slightly oedematous and infiltration of a small number of inflammatory cells consisting mainly of mononuclear cells accompanied by a few PMN were observed (Figure 3a) . In contrast, considerable oedematous swelling of the subcutaneous tissues and moderate infiltration of PMN and mononuclear cells was observed in the zymosan-CMC group ( Figure  3b) . A characteristic feature of the zymosan-CMC group is the formation of a prominent layer of aggregated PMN sticking onto the inner surface of the pouch wall. This layer of aggregated cells could be completely removed by incubating the tissues at 37°C for 4 h with 0.05 % trypsin in Hanks' balanced salt solution (figure 3c). On day 5, heavy deposition of a basophilic amorphous foreign substance (thought to be residual CMC) was observed in the pouch wall subcutaneous tissues of the vehicle-CMC group (Figure 4a) , whilst in the zymosan-CMC group massive proliferation of granulation tissues was observed ( Figure 4b ) together with a small amount of the basophilic amorphous foreign substance in the granulation tissues. Effect of local application of K-76COONa on zymosan-air-pouch inflammation Zymosan is well known as an agent capable of activating the alternative pathway of the complement system (Pillemer et al., 1954) . Assuming that complement activation plays an important role in the development of the zymosan-air-pouch inflammation, we attempted to investigate whether K76COONa, a specific inhibitor of the activation of the fifth component of complement (Hong et al., 1979) , could inhibit the development of the zymosan-air-pouch inflammation. K-76COONa was injected into the air-pouch after being mixed with the zymosan-CMC; 6 h later the rats were killed. The results summarized in Figure 5 show the effects of locally injected K-76COONa on both the leukocyte and pouch fluid accumulation in the period of the first Effect of local application of dexamethasone on zymosan-air-pouch inflammation One possible mechanism for the anti-inflammatory action of glucocorticoids is an indirect inhibitory effect on the generation of proinflammatory metabolites of arachidonic acid via a peptide-mediated inhibitory action on phospholipase A2 (Hong & Levine, 1976; Bray & Gordon, 1978; Blackwell, Flower, Nijkamp & Vane, 1978; Robinson, McGuire, Bastian, Kantrowitz & Levine, 1978; Blackwell, Carnuccio, Di Rosa, Flower, Parente & Persico, 1980; Hirata, Schiffmann, Venkatasubramanian, Salomon & Axelrod, 1980) . With reference to the above concept, the effect of dexamethasone on the zymosan-air-pouch inflammation was examined in an attempt to collect further data on the anti-inflammatory action of this steroid. Dexamethasone was administered locally into the pouch immediately after the injection of the zymosan-CMC, and animals were killed 6 h later. The results are summarized in Figure 6 . In contrast to the results from the experiment with K-76COONa, dexamethasone exerted a dose-dependent suppressive effect on pouch fluid accumulation, without altering the total number of leukocytes emigrating into the pouch fluid. However, although dexamethasone did not alter the overall number of leukocytes in the pouch, it significantly affected their distribution between free and aggregated states in a dose-dependent manner (Figure 6 ).
Effect of local application of dexamethasone on casein-air-pouch inflammation
As the local application of dexamethasone in the zymosan-air-pouch inflammation did not inhibit leukocyte accumulation at the inflammatory locus (Figure 6 ), a similar experiment was designed with alkali-solubilized casein used in place of zymosan as a chemoattractant for leukocytes (Wilkinson, 1972) . Using the same experimental design we found that accumulation of pouch fluid and migration of leukocytes into the pouch were both markedly inhibited in a dose-dependent manner by dexamethasone (Figure 7) . 
Discussion
The air-pouch method for the induction of inflammation models was first introduced by Selye with the aid of croton oil as a phlogistic agent (Selye, 1953) . We have developed various modifications of his original method by introducing a variety of characteristic stimuli involving simple foreign substances such as carrageenan (Fukuhara & Tsurufuji, 1969; Tsurufuji, Sato, Min & Ohuchi, 1978) , carboxymethyl cellulose (Ishikawa, Mori & Tsurufuji, 1968) and more complex allergic mechanisms Ohuchi, Yoshino, Kanaoka, Tsurufuji & Levine, 1982) . In the course of those studies it became evident that the air-pouch method has a definite advantage in supplying a suitable space for the induction of inflammatory responses (Pillemer et al., 1954) , it is likely that immune adherence of PMN with C3b-coated zymosan particles is responsible for the formation of the aggregated layer of leukocytes.
Complement-derived chemotactic factor(s), especially C5a and/or C5a des Arg (Borel & Feurer, 1978; Webster, Hong, Johnston & Henson, 1980) , seem to play an important role in the accumulation of PMN in the pouch, since K-76COONa, a specific inhibitor of the activation of C5 (Hong et al., 1979) , reduced the number of leukocytes in the zymosanair-pouch inflammation ( Figure 5 ), whereas this drug failed to affect leukocyte accumulation in the caseinair-pouch inflammation (data not shown), in which alkali-solubilized casein, known as a potent chemoattractant (Wilkinson, 1972) , was used instead of zymosan. This result also suggests that anticomplementary agents might be effective therapeutic agents in some inflammatory and allergic diseases. However, in spite of the inhibition of leukocyte emigration by K-76COONa, fluid exudation in the pouch was not inhibited by this agent. Further investigation is needed to elucidate the mechanisms for this different effect of K-76COONa.
In contrast with K-76COONa, the potent antiinflammatory steroid, dexamethasone, did not inhibit leukocyte migration in spite of significantly suppressing the fluid exudation ( Figure 6 ). Potent inhibitory effects of glucocorticoids on leukocyte accumulation and plasma exudation at the inflammatory locus have been frequently reported in the literature (e.g. Ward, 1966; Ishikawa et al., 1968; Higgs, Flower & Vane, 1979; Ohuchi etal., 1982) . In agreement with this general concept, dexamethasone exerted potent inhibitory effects not only on fluid exudation but also on leukocyte accumulation in the casein-air-pouch inflammation (Figure 7 ). Dose levels, time and route of administration of dexamethasone in this latter casein-air-pouch experiment were the same as for the zymosan-air-pouch inflammation experiment. Therefore, the failure of dexamethasone to inhibit leukocyte migration in the zymosan-air-pouch inflammation appears to be a peculiar case in respect to the mode of action of the anti-inflammatory steroid. As a matter of fact, leukocyte migration in vivo towards complement-derived chemoattractant(s) might be refractory to the antiinflammatory action of glucocorticoids. Further investigation is required to elucidate these questions.
In summary, this new experimental model appears to be useful for quantitative measurements and biochemical analysis of the inflammatory process in which complement activation plays an important role because inflammatory exudate in the pouch, inflammatory cells free in the pouch fluid as well as those aggregated on the inner surface of the pouch walls and granulation tissues may all be easily collected quantitatively.
